203 related articles for article (PubMed ID: 26758277)
1. Brain-Derived Neurotrophic Factor Knockdown Blocks the Angiogenic and Protective Effects of Angiotensin Modulation After Experimental Stroke.
Fouda AY; Alhusban A; Ishrat T; Pillai B; Eldahshan W; Waller JL; Ergul A; Fagan SC
Mol Neurobiol; 2017 Jan; 54(1):661-670. PubMed ID: 26758277
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009
[TBL] [Abstract][Full Text] [Related]
3. AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.
Alhusban A; Kozak A; Ergul A; Fagan SC
J Pharmacol Exp Ther; 2013 Feb; 344(2):348-59. PubMed ID: 23211364
[TBL] [Abstract][Full Text] [Related]
4. Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats.
Krikov M; Thone-Reineke C; Müller S; Villringer A; Unger T
J Hypertens; 2008 Mar; 26(3):544-52. PubMed ID: 18300867
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension.
Alhusban A; Kozak A; Pillai B; Ahmed H; Sayed MA; Johnson MH; Ishrat T; Ergul A; Fagan SC
PLoS One; 2017; 12(6):e0178867. PubMed ID: 28640888
[TBL] [Abstract][Full Text] [Related]
6. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
[TBL] [Abstract][Full Text] [Related]
7. Sequential Therapy with Minocycline and Candesartan Improves Long-Term Recovery After Experimental Stroke.
Soliman S; Ishrat T; Fouda AY; Patel A; Pillai B; Fagan SC
Transl Stroke Res; 2015 Aug; 6(4):309-22. PubMed ID: 26004281
[TBL] [Abstract][Full Text] [Related]
8. Low-dose candesartan enhances molecular mediators of neuroplasticity and subsequent functional recovery after ischemic stroke in rats.
Ishrat T; Pillai B; Soliman S; Fouda AY; Kozak A; Johnson MH; Ergul A; Fagan SC
Mol Neurobiol; 2015; 51(3):1542-53. PubMed ID: 25084762
[TBL] [Abstract][Full Text] [Related]
9. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke.
Saad MA; Abbas AM; Boshra V; Elkhateeb M; El Aal IA
Acta Physiol Hung; 2010 Jun; 97(2):159-71. PubMed ID: 20511125
[TBL] [Abstract][Full Text] [Related]
11. Silencing VEGF-B Diminishes the Neuroprotective Effect of Candesartan Treatment After Experimental Focal Cerebral Ischemia.
Ishrat T; Soliman S; Eldahshan W; Pillai B; Ergul A; Fagan SC
Neurochem Res; 2018 Oct; 43(10):1869-1878. PubMed ID: 30088238
[TBL] [Abstract][Full Text] [Related]
12. Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke.
Kozak A; Ergul A; El-Remessy AB; Johnson MH; Machado LS; Elewa HF; Abdelsaid M; Wiley DC; Fagan SC
Stroke; 2009 May; 40(5):1870-6. PubMed ID: 19265050
[TBL] [Abstract][Full Text] [Related]
13. Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain.
Schmerbach K; Schefe JH; Krikov M; Müller S; Villringer A; Kintscher U; Unger T; Thoene-Reineke C
Brain Res; 2008 May; 1208():225-33. PubMed ID: 18378216
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction.
Gaur V; Kumar A
Inflammopharmacology; 2011 Aug; 19(4):205-14. PubMed ID: 21061073
[TBL] [Abstract][Full Text] [Related]
15. Compound 21 is pro-angiogenic in the brain and results in sustained recovery after ischemic stroke.
Alhusban A; Fouda AY; Bindu Pillai ; Ishrat T; Soliman S; Fagan SC
J Hypertens; 2015 Jan; 33(1):170-80. PubMed ID: 25304472
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of postischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia.
Fu H; Hosomi N; Pelisch N; Nakano D; Liu G; Ueno M; Miki T; Masugata H; Sueda Y; Itano T; Matsumoto M; Nishiyama A; Kohno M
J Hypertens; 2011 Nov; 29(11):2210-9. PubMed ID: 21934531
[TBL] [Abstract][Full Text] [Related]
17. Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: role of vascular endothelial growth factors A and B.
Soliman S; Ishrat T; Pillai A; Somanath PR; Ergul A; El-Remessy AB; Fagan SC
J Pharmacol Exp Ther; 2014 Jun; 349(3):444-57. PubMed ID: 24681872
[TBL] [Abstract][Full Text] [Related]
18. The Neuroprotective Effects of Flaxseed Oil Supplementation on Functional Motor Recovery in a Model of Ischemic Brain Stroke: Upregulation of BDNF and GDNF.
Bagheri A; Talei S; Hassanzadeh N; Mokhtari T; Akbari M; Malek F; Jameie SB; Sadeghi Y; Hassanzadeh G
Acta Med Iran; 2017 Dec; 55(12):785-792. PubMed ID: 29373886
[TBL] [Abstract][Full Text] [Related]
19. Different protective and reparative effects of olmesartan in stroke according to time of administration and withdrawal.
Gutiérrez-Fernández M; Fuentes B; Rodríguez-Frutos B; Ramos-Cejudo J; Otero-Ortega L; Díez-Tejedor E
J Neurosci Res; 2015 May; 93(5):806-14. PubMed ID: 25524827
[TBL] [Abstract][Full Text] [Related]
20. The neuroprotective effects of R-phenibut after focal cerebral ischemia.
Vavers E; Zvejniece L; Svalbe B; Volska K; Makarova E; Liepinsh E; Rizhanova K; Liepins V; Dambrova M
Pharmacol Res; 2016 Nov; 113(Pt B):796-801. PubMed ID: 26621244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
